Nuvelo, Orchid, Illumina, Oscient Among 26 Additions to Nasdaq Biotech Index | GenomeWeb

NEW YORK, May 18 (GenomeWeb News) - Several genomics companies, including Nuvelo, Orchid, Illumina, and Oscient (formerly Genome Therapeutics), were among 26 securities added to the Nasdaq Biotechnology Index yesterday.

The change in the index will become effective with the market open next Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.